share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director SMITH JAMES C

SEC announcement ·  Apr 27 01:28
Summary by Futu AI
James C. Smith, a reporting person for Pfizer Inc. [PFE], has been involved in a transaction with the company's stock. The action took place on April 25, 2024. However, the details regarding the nature of the transaction, such as the number of shares traded, the transaction price, and the resulting shareholding, have not been disclosed. Investors are advised to await further information for a complete understanding of the impact of this event on their investment decisions.
James C. Smith, a reporting person for Pfizer Inc. [PFE], has been involved in a transaction with the company's stock. The action took place on April 25, 2024. However, the details regarding the nature of the transaction, such as the number of shares traded, the transaction price, and the resulting shareholding, have not been disclosed. Investors are advised to await further information for a complete understanding of the impact of this event on their investment decisions.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.